Author

Yu Xin

h-index 2 View on Semantic Scholar

We have 2 of 4 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

METTL3-mediated m6A modification of RBM39 promotes cancer stemness and tumor progression in head and neck squamous cell carcinoma

Pan-cancer analysis showed that RBM39 is aberrantly expressed in multiple cancers and is significantly associated with patient prognosis, suggesting its diagnostic value, and RBM39 may serve as a potential diagnostic and therapeutic target for HNSC.

Yu Xin, Wen-Zhi Deng, Chu-Yang Jiang et al. · Discover Oncology · 0 citations

Review Open access Jul 2026

Primary and acquired resistance to immunotherapy in NSCLC

This review summarizes immune resistance in NSCLC through a framework that distinguishes primary resistance from acquired resistance, and discusses mechanism-based biomarkers, translational correlates, and rational therapeutic strategies for overcoming resistance.

Bo Yuan, Wenzhi Deng, Juan Luo et al. · Frontiers in Immunology · 0 citations